Introduction
Pulmonary hypertension is diagnosed by combining clinical suspicion with targeted testing that measures how the heart and lungs are functioning. The condition refers to elevated pressure in the pulmonary arteries, the vessels that carry blood from the right side of the heart to the lungs. Because this pressure can rise for different reasons, diagnosis is not based on symptoms alone. Medical professionals work to confirm whether pulmonary pressure is truly elevated, identify the underlying cause, and determine whether the right side of the heart has been affected.
Accurate diagnosis matters because pulmonary hypertension can progress silently at first, yet later lead to right heart strain, reduced exercise tolerance, fainting, fluid retention, and eventually right heart failure. Several forms of the disease require different treatments, so the diagnostic process must distinguish pulmonary arterial hypertension from pulmonary hypertension caused by left heart disease, lung disease, chronic blood clots, or other disorders.
Recognizing Possible Signs of the Condition
Suspicion of pulmonary hypertension usually begins when a patient reports symptoms that suggest the heart or lungs are not delivering enough oxygen during activity. The most common early symptom is shortness of breath with exertion, especially when climbing stairs or walking uphill. Fatigue, reduced stamina, chest pressure, palpitations, lightheadedness, and fainting spells can also occur. Some people notice swelling in the ankles or legs, abdominal bloating, or a feeling of fullness from liver congestion as the condition advances and right heart function worsens.
These symptoms are not specific to pulmonary hypertension, but certain patterns raise concern. For example, breathlessness that seems greater than expected for the degree of lung disease, unexplained exercise limitation in a younger person, or syncope during activity may prompt further evaluation. On examination, a clinician may also note a loud second heart sound, a right ventricular heave, distended neck veins, low oxygen saturation, or peripheral edema. When such findings appear together, pulmonary hypertension becomes a diagnostic consideration.
Medical History and Physical Examination
The diagnostic process begins with a detailed history. Clinicians ask when symptoms started, whether they occur at rest or only with activity, and whether they are worsening over time. They also ask about prior blood clots, connective tissue disease, congenital heart defects, liver disease, sleep apnea, chronic lung disease, stimulant or appetite suppressant use, and family history of pulmonary hypertension. These details help identify causes that may predispose a person to elevated pulmonary artery pressure.
Medication review is important because some drugs and toxins can damage the pulmonary circulation. History may also reveal risk factors for chronic thromboembolic pulmonary hypertension, such as previous pulmonary embolism or deep vein thrombosis. In addition, clinicians look for signs of systemic illness, since diseases such as scleroderma, lupus, or portal hypertension can be associated with pulmonary vascular remodeling.
During the physical examination, healthcare professionals assess breathing rate, oxygen level, heart rate, blood pressure, and signs of fluid overload. They listen for murmurs, especially those suggesting tricuspid regurgitation or underlying left-sided valve disease. They inspect the neck veins, check for swelling in the legs, and look for evidence of enlarged liver or ascites. The exam does not diagnose pulmonary hypertension by itself, but it helps determine whether the condition is likely and whether the disease may already be affecting right ventricular performance.
Diagnostic Tests Used for Pulmonary hypertension
Several tests are used to evaluate suspected pulmonary hypertension. No single screening test confirms every case. Instead, doctors use a sequence of laboratory studies, imaging tests, functional assessment, and sometimes invasive hemodynamic measurement. The goal is to determine whether pulmonary artery pressure is elevated, why it is elevated, and how severe the condition is.
Laboratory tests are often ordered first to look for associated conditions and to assess organ strain. Blood tests may include a complete blood count to evaluate anemia or polycythemia, kidney and liver function tests, thyroid studies, and markers of autoimmune disease such as antinuclear antibodies or other connective tissue disease panels. Brain natriuretic peptide, or BNP, and its related marker NT-proBNP may be elevated when the right side of the heart is under strain. These tests do not diagnose pulmonary hypertension alone, but they provide clues about severity and underlying causes.
Electrocardiography is commonly performed. It may show right axis deviation, right atrial enlargement, or signs of right ventricular hypertrophy. While a normal ECG does not rule out the disease, abnormalities can support suspicion and point toward right heart involvement.
Chest X-rays can show enlarged pulmonary arteries, enlargement of the right side of the heart, or changes suggesting chronic lung disease. However, chest radiography is more useful as a clue than as proof. A normal film does not exclude pulmonary hypertension, especially in early disease.
Echocardiography is one of the most important noninvasive tests. This ultrasound examination estimates pulmonary artery pressure by measuring the velocity of tricuspid regurgitation and evaluating right ventricular size and function. It can also identify structural heart disease, left ventricular dysfunction, valvular abnormalities, and shunts that might explain the pressure elevation. Because echocardiography can assess both the heart and indirect signs of pulmonary hypertension, it often guides the next diagnostic step.
Imaging of the lungs and pulmonary vessels may also be necessary. A ventilation-perfusion scan, or V/Q scan, is particularly useful for detecting chronic blood clots in the lung circulation. A normal V/Q scan makes chronic thromboembolic pulmonary hypertension much less likely. Computed tomography, often with pulmonary angiography, can show enlarged central pulmonary arteries, lung parenchymal disease, interstitial changes, emphysema, or chronic clot burden. CT findings help distinguish vascular disease from lung disorders that raise pulmonary pressure secondarily.
Pulmonary function tests evaluate how well the lungs move air and transfer gas. Spirometry, lung volume measurements, and diffusion capacity for carbon monoxide, or DLCO, are commonly used. Low diffusion capacity can be seen in pulmonary vascular disease and some interstitial lung diseases. Arterial blood gas testing may reveal low oxygen levels or abnormal carbon dioxide values, especially in advanced lung disease or sleep-related breathing disorders.
Exercise testing, especially the six-minute walk test, measures functional capacity and helps quantify the effect of the disease on daily activity. In some centers, cardiopulmonary exercise testing provides more detailed data on oxygen use, ventilation, and circulatory response during exertion. These functional tests do not confirm the diagnosis on their own, but they help establish how severely the condition limits the patient.
The definitive test for pulmonary hypertension is right heart catheterization. This invasive procedure measures pressures directly inside the right atrium, right ventricle, pulmonary artery, and pulmonary capillaries. It also measures cardiac output and pulmonary vascular resistance. Right heart catheterization confirms whether pulmonary hypertension is present and helps classify the type. In pulmonary arterial hypertension, the mean pulmonary artery pressure is elevated, the pulmonary capillary wedge pressure is not elevated in a way that suggests left heart congestion, and pulmonary vascular resistance is increased. This distinction is essential because it separates disease of the pulmonary arteries from pressure elevation caused by left-sided heart problems.
In selected cases, additional studies may be used. Sleep studies can identify obstructive sleep apnea or hypoventilation syndromes. Blood tests may be repeated to track biomarkers over time. In rare situations, tissue examination from lung biopsy is considered, but this is not routine because biopsy can be risky in patients with pulmonary hypertension. When performed, it may help identify unusual lung or vascular disorders that are not clear from noninvasive testing.
Interpreting Diagnostic Results
Doctors interpret diagnostic findings by combining the pressure measurements with the overall clinical picture. An elevated estimated pressure on echocardiography raises concern, but confirmation requires right heart catheterization. The catheter data show whether pressure is elevated because blood is flowing through narrowed pulmonary vessels, because the left side of the heart is backing up into the lungs, or because there is another cause.
The pattern of pressures is especially important. If the pulmonary capillary wedge pressure is normal while pulmonary artery pressure and vascular resistance are high, the findings support pulmonary arterial hypertension or another pre-capillary form of pulmonary hypertension. If wedge pressure is elevated, the problem often lies in left-sided heart disease. If imaging shows chronic clotting, the diagnosis may be chronic thromboembolic pulmonary hypertension. Thus, interpretation focuses not only on whether pulmonary pressure is high, but also on the mechanism that produced it.
Severity is judged by hemodynamic values, right ventricular function, exercise capacity, oxygen level, and biomarker elevation. A patient may have only mildly elevated pressures but substantial symptoms if right ventricular compensation is poor. Conversely, a person with chronic lung disease may have elevated pressures driven partly by low oxygen and lung remodeling rather than primary vascular disease. The clinical meaning of the numbers depends on the broader context.
Conditions That May Need to Be Distinguished
Several disorders can resemble pulmonary hypertension or produce similar symptoms. Left-sided heart failure is a major alternative diagnosis because it can raise pressure in the pulmonary circulation without primary disease of the pulmonary arteries. Valve disease, particularly mitral valve disease, can do the same. Echocardiography and catheterization are key to distinguishing these causes.
Chronic lung disease, including chronic obstructive pulmonary disease, interstitial lung disease, and severe sleep apnea, can lead to shortness of breath and secondary pulmonary hypertension. Pulmonary function tests, CT imaging, oxygen studies, and sleep testing help clarify these possibilities. Chronic thromboembolic disease is another important distinction because it may be treated with surgery or procedures aimed at removing obstructing clots.
Other conditions such as anemia, thyroid disease, deconditioning, obesity, and certain neuromuscular disorders can also produce exertional breathlessness. The diagnostic challenge is to avoid attributing symptoms to pulmonary hypertension before evidence supports it. Medical evaluation therefore aims to separate pressure elevation in the pulmonary circulation from more common causes of reduced exercise tolerance.
Factors That Influence Diagnosis
The diagnostic approach varies depending on age, symptom severity, and associated illnesses. In younger patients with unexplained exertional symptoms, clinicians may consider inherited or idiopathic pulmonary arterial hypertension earlier. In older adults, left heart disease and lung disease are more common explanations, so testing often begins with careful assessment of cardiac function and pulmonary status.
Comorbid conditions can make interpretation more complex. Obesity, chronic kidney disease, connective tissue disease, liver disease, or a history of venous thromboembolism may alter which tests are prioritized. Severe symptoms, syncope, or evidence of right heart failure usually prompt faster and more comprehensive evaluation. Conversely, subtle symptoms may lead to a slower workup that begins with noninvasive studies before proceeding to catheterization.
Access to specialized centers also affects diagnosis. Pulmonary hypertension is often best evaluated by clinicians experienced in interpreting hemodynamic data and integrating imaging, laboratory, and functional findings. In difficult cases, referral to a pulmonary hypertension center improves the chance of correct classification.
Conclusion
Pulmonary hypertension is identified through a stepwise process that combines clinical suspicion with objective testing. Symptoms such as exertional breathlessness, fatigue, chest discomfort, fainting, and swelling may raise concern, but they are not enough to establish the diagnosis. Medical history, physical examination, laboratory studies, imaging, pulmonary function tests, and exercise assessment help build the case and search for the underlying cause. Right heart catheterization then confirms the diagnosis by directly measuring pulmonary pressures and vascular resistance.
Because different diseases can produce similar symptoms and different forms of pulmonary hypertension require different treatment strategies, accurate diagnosis is essential. The process is less about a single abnormal result and more about assembling a coherent picture of how the pulmonary circulation, the heart, and the lungs are functioning together. That combination of clinical reasoning and targeted testing is what allows doctors to identify pulmonary hypertension reliably.